263 related articles for article (PubMed ID: 32932563)
1. Texture Analysis of Three-Dimensional MRI Images May Differentiate Borderline and Malignant Epithelial Ovarian Tumors.
Ye R; Weng S; Li Y; Yan C; Chen J; Zhu Y; Wen L
Korean J Radiol; 2021 Jan; 22(1):106-117. PubMed ID: 32932563
[TBL] [Abstract][Full Text] [Related]
2. MRI-Based Machine Learning for Differentiating Borderline From Malignant Epithelial Ovarian Tumors: A Multicenter Study.
Li Y; Jian J; Pickhardt PJ; Ma F; Xia W; Li H; Zhang R; Zhao S; Cai S; Zhao X; Zhang J; Zhang G; Jiang J; Zhang Y; Wang K; Lin G; Feng F; Lu J; Deng L; Wu X; Qiang J; Gao X
J Magn Reson Imaging; 2020 Sep; 52(3):897-904. PubMed ID: 32045064
[TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of the MRI features in the differentiation of benign, borderline, and malignant epithelial ovarian tumors.
Xiao F; Zhang L; Yang S; Peng K; Hua T; Tang G
J Ovarian Res; 2022 Jan; 15(1):13. PubMed ID: 35062992
[TBL] [Abstract][Full Text] [Related]
4. MRI-Based Multiple Instance Convolutional Neural Network for Increased Accuracy in the Differentiation of Borderline and Malignant Epithelial Ovarian Tumors.
Jian J; Li Y; Xia W; He Z; Zhang R; Li H; Zhao X; Zhao S; Zhang J; Cai S; Wu X; Gao X; Qiang J
J Magn Reson Imaging; 2022 Jul; 56(1):173-181. PubMed ID: 34842320
[TBL] [Abstract][Full Text] [Related]
5. MRI features and score for differentiating borderline from malignant epithelial ovarian tumors.
Li YA; Qiang JW; Ma FH; Li HM; Zhao SH
Eur J Radiol; 2018 Jan; 98():136-142. PubMed ID: 29279152
[TBL] [Abstract][Full Text] [Related]
6. The enhanced T
Han X; Sun M; Wang M; Fan R; Chen D; Xie L; Liu A
Eur J Radiol; 2019 Sep; 118():187-193. PubMed ID: 31439240
[TBL] [Abstract][Full Text] [Related]
7. Diffusion kurtosis imaging for differentiating borderline from malignant epithelial ovarian tumors: A correlation with Ki-67 expression.
Li HM; Zhao SH; Qiang JW; Zhang GF; Feng F; Ma FH; Li YA; Gu WY
J Magn Reson Imaging; 2017 Nov; 46(5):1499-1506. PubMed ID: 28295854
[TBL] [Abstract][Full Text] [Related]
8. Value of normalized apparent diffusion coefficients in differentiating between borderline and malignant epithelial ovarian tumors.
Lu J; Pi S; Ma FH; Zhao SH; Li HM; Cai SL; Qiang JW
Eur J Radiol; 2019 Sep; 118():44-50. PubMed ID: 31439257
[TBL] [Abstract][Full Text] [Related]
9. Application of contrast-enhanced dual-energy spectral CT for differentiating borderline from malignant epithelial ovarian tumours.
Han X; Li B; Sun M; Li J; Li Y; Liu A
Clin Radiol; 2021 Aug; 76(8):585-592. PubMed ID: 34059294
[TBL] [Abstract][Full Text] [Related]
10. The serum CA-125 concentration data assists in evaluating CT imaging information when used to differentiate borderline ovarian tumor from malignant epithelial ovarian tumors.
Shin JE; Choi HJ; Kim MH; Cho KS
Korean J Radiol; 2011; 12(4):456-62. PubMed ID: 21852906
[TBL] [Abstract][Full Text] [Related]
11. Value of conventional magnetic resonance imaging texture analysis in the differential diagnosis of benign and borderline/malignant phyllodes tumors of the breast.
Li X; Jiang N; Zhang C; Luo X; Zhong P; Fang J
Cancer Imaging; 2021 Mar; 21(1):29. PubMed ID: 33712070
[TBL] [Abstract][Full Text] [Related]
12. Multiple instance convolutional neural network with modality-based attention and contextual multi-instance learning pooling layer for effective differentiation between borderline and malignant epithelial ovarian tumors.
Jian J; Xia W; Zhang R; Zhao X; Zhang J; Wu X; Li Y; Qiang J; Gao X
Artif Intell Med; 2021 Nov; 121():102194. PubMed ID: 34763809
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric MRI for differentiation of borderline ovarian tumors from stage I malignant epithelial ovarian tumors using multivariate logistic regression analysis.
Denewar FA; Takeuchi M; Urano M; Kamishima Y; Kawai T; Takahashi N; Takeuchi M; Kobayashi S; Honda J; Shibamoto Y
Eur J Radiol; 2017 Jun; 91():116-123. PubMed ID: 28629557
[TBL] [Abstract][Full Text] [Related]
14. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
[TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation.
Zhao SH; Qiang JW; Zhang GF; Ma FH; Cai SQ; Li HM; Wang L
Eur Radiol; 2014 Sep; 24(9):2292-9. PubMed ID: 24871335
[TBL] [Abstract][Full Text] [Related]
16. Application Values of 2D and 3D Radiomics Models Based on CT Plain Scan in Differentiating Benign from Malignant Ovarian Tumors.
Li S; Liu J; Xiong Y; Han Y; Pang P; Luo P; Fan B
Biomed Res Int; 2022; 2022():5952296. PubMed ID: 35224097
[TBL] [Abstract][Full Text] [Related]
17. Radiomics derived from dynamic contrast-enhanced MRI pharmacokinetic protocol features: the value of precision diagnosis ovarian neoplasms.
Song XL; Ren JL; Zhao D; Wang L; Ren H; Niu J
Eur Radiol; 2021 Jan; 31(1):368-378. PubMed ID: 32767049
[TBL] [Abstract][Full Text] [Related]
18. MRI texture features differentiate clinicopathological characteristics of cervical carcinoma.
Wang M; Perucho JAU; Tse KY; Chu MMY; Ip P; Lee EYP
Eur Radiol; 2020 Oct; 30(10):5384-5391. PubMed ID: 32382845
[TBL] [Abstract][Full Text] [Related]
19. Value of diffusion-weighted imaging combined with conventional magnetic resonance imaging in the diagnosis of thecomas/fibrothecomas and their differential diagnosis with malignant pelvic solid tumors.
Yin B; Li W; Cui Y; Chu C; Ding M; Chen J; Zhang P; Wu X
World J Surg Oncol; 2016 Jan; 14(1):5. PubMed ID: 26744173
[TBL] [Abstract][Full Text] [Related]
20. Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors.
Huang K; Xu S; Wang J; Ge L; Xu J; Jia X
J Ovarian Res; 2023 Feb; 16(1):37. PubMed ID: 36759870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
